Skip to content

DR. OLIVIA VANDEPUT

Active
Private limited companyfounded 2013active for 13 yearsVeldonkstraat 17, 3120 Tremelo, BelgiumKBO/BCE: BE 0541.543.575
Summary

DR. OLIVIA VANDEPUT has been active since 2013 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €303,822 and a net result of €47,324. Equity has been growing by about 50% per year since 2019. Its solvency ranks better than 60% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 23-10-2013 Normal situation
Activity
General medical practice NACE 86210and 4 others
Joint committee
330 Paritair Comité voor de gezondheidsinrichtingen en -diensten · annual accounts 31-03-2022
Establishment units
2.225.902.550 2223 Heist-op-den-Berg, since 01-12-2013
2.225.902.946 3120 Tremelo, since 01-12-2013
Financial year end
31 December
Peppol
Reachable since 09-07-2025

Board and ownership

Board

Financial position

94 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€104,299
▼ 16.7%
Turnover
≈ €190,000
estimated
Profit
€47,324
▼ 11.4%
Equity
€303,822
▲ 18.4%
Total assets
€418,139
▲ 4.8%
Staff
≈ 0 FTE
estimated
Filed on 30-06-2026, 31 days before the deadline
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 3.99, cash €85,591Equity €303,822 (72.7% of total assets)Size: total assets €418,139Show the evidence

Checked score

Score 2025
94 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 50% of micro companies in human health (NACE 86)
Financial strength · tick: 2025
Strong
Solvency 98+9
equity 72.7% of total assets
Liquidity 76-7
short-term debt 10.0% · cash 20.5%
Profitability 83-2
return on assets 11.3%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025highest value 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026lowest value 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value 11-2026: < 0.1%● unchanged vs 10-2026lowest value
Credit of up to €25,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 3.99, above the usual 1.5. Short-term debt is 10% and cash 20.5% of total assets. 27.3% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 61% of them on solvency, 57% on liquidity and 31% on profitability.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 3.99, cash €85,591
NBB · annual accounts
lowers risk · Equity €303,822 (72.7% of total assets)
NBB · annual accounts
lowers risk · Size: total assets €418,139
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
31 days early
2025
31 days early
2024
7 days early
2023
on the day
2022
29 days late
2021
22 days late
2020
6 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 2 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: 8 profitable years in a rowprofit 2025: €47,324 8 years View
  • Positive: Filed on time since financial year 2023accounts within the deadline every year 4 years View

Recent changes

  1. · Gazette deed Algemene Vergadering - Boekjaar
  2. · Gazette deed Reappointment: Olivia Vandeput (director)
  3. · Gazette deed Incorporation
All 16 events

Comparable companies

These companies have the same main activity as DR. OLIVIA VANDEPUT: general medical practice (NACE 86210). They are comparable in size and age: total assets between €357,000 and €473,000, founded between 2011 and 2014.

CompanyTotal assetsGross margin
DR. OLIVIA VANDEPUT Tremelo€418,139€104,299
Medisch Kabinet Dokter Haemels BV, algemene geneeskunde Boortmeerbeek€430,553€109,916
DOKTER NEL VERHEYEN, HUISARTS Tervuren€356,686€110,808
HUISARTSENPRAKTIJK WILLEMS SYLVIE Oosterzele€390,883€107,151
DR. M. VRIJENS Hasselt€388,165€103,701
Docteur Patrick SAUVEUR Ans€412,195€107,482
DOCTEUR KULACOGLU IKER Herstal€473,147€101,229
Full comparison

Key facts about DR. OLIVIA VANDEPUT

What is the company number of DR. OLIVIA VANDEPUT?
The company number of DR. OLIVIA VANDEPUT is 0541.543.575. The VAT number is the same number with BE in front: BE 0541.543.575.
Where is DR. OLIVIA VANDEPUT based?
The registered office is at Veldonkstraat 17, 3120 Tremelo.Company details
What does DR. OLIVIA VANDEPUT do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DR. OLIVIA VANDEPUT?
The legal form of DR. OLIVIA VANDEPUT is Private limited company (BV).
When was DR. OLIVIA VANDEPUT founded?
DR. OLIVIA VANDEPUT was founded on 23-10-2013.
Is DR. OLIVIA VANDEPUT still active?
Yes, DR. OLIVIA VANDEPUT is an active enterprise in the KBO register.
How many employees does DR. OLIVIA VANDEPUT have?
DR. OLIVIA VANDEPUT had an average of 1 full-time equivalents in financial year 2022, according to the filed annual accounts.Financials
Which joint committee does DR. OLIVIA VANDEPUT fall under?
In its 31-03-2022 annual accounts, DR. OLIVIA VANDEPUT states joint committee 330 (Paritair Comité voor de gezondheidsinrichtingen en -diensten).
What is the turnover of DR. OLIVIA VANDEPUT?
The turnover in financial year 2025 is ≈ €190,000. This figure is estimated from the gross margin of €104,299 and 30 comparable companies (NACE 86210). It probably lies between €150,000 and €230,000.
Is DR. OLIVIA VANDEPUT profitable?
In financial year 2025, DR. OLIVIA VANDEPUT made a profit of €47,324.
Where can I find the annual accounts of DR. OLIVIA VANDEPUT?
DR. OLIVIA VANDEPUT filed 12 annual accounts with the National Bank of Belgium, the latest for financial year 2025.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.